Psychology Wiki

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)

Anticonvulsive drugs (also called anticonvulsants and antiepileptic drugs,abbreviated "AEDs"), belong to a diverse group of pharmaceuticals used in prevention of the occurrence of convulsions, spasms and epileptic seizures. More and more, anticonvulsants are also finding ways into the treatment of bipolar disorder, since many seem to act as mood stabilizers. The goal of an anticonvulsant is to suppress the rapid and excessive firing of neurons that start a seizure. Failing this, a good anticonvulsant would prevent the spread of the seizure within the brain and offer protection against possible excitotoxic effects that may result in brain damage. However, anticonvulsants themselves have been linked to lowered IQ[1] and cell apoptosis.[2]

Many anticonvulsants block Sodium (Na+) channels, Calcium (Ca2+) channels, AMPA receptors or NMDA receptors. Some anticonvulsants inhibit the metabolism of GABA or increase its release.

Some anticonvulsants have shown antiepileptogenic effects in animal models of epilepsy. That is, they either prevent the expected development of epilepsy or can halt or reverse the progression of epilepsy. However, no drug has shown this effect in human trials.[3]


The usual method of achieving approval for a drug is to show it is effective when compared against placebo, or that it is more effective than an existing drug. In monotherapy (where only one drug is taken) it is not ethical to conduct a trial with placebo on a new drug of uncertain efficacy. This is because untreated epilepsy leaves the patient at significant risk of death. Therefore, almost all new epilepsy drugs are initially approved only as adjunctive (add-on) therapies. Patients whose epilepsy is currently uncontrolled by their medication (i.e., it is refractory to treatment) are selected to see if supplementing the medication with the new drug leads to an improvement in seizure control. Any reduction in the frequency of seizures is compared against a placebo.[3]

Once there is confidence that a drug is likely to be effective in monotherapy, trials are conducted where the drug is compared to an existing standard. For partial-onset seizures, this is typically carbamazepine. Despite the launch of over ten drugs since 1990, no new drug has been shown to be more effective than the older set, which includes carbamazepine, valproate and phenytoin. The lack of superiority over existing treatment, combined with the lack of placebo-controlled trials, means that few modern drugs have earned FDA approval as initial monotherapy. In contrast, Europe only requires equivalence to existing treatments, and has approved many more. Despite their lack of FDA approval, the American Academy of Neurology and the American Epilepsy Society still recommend a number of these new drugs as initial monotherapy.[3]


In the following list, the dates in parentheses are the earliest approved use of the drug.


Main article: Aldehydes

  • Paraldehyde (1882). One of the earliest anticonvulsants. Still used to treat status epilepticus, particularly where there are no resuscitation facilities.

Aromatic allylic alcohols

  • Stiripentol (2001 - limited availability). Indicated for the treatment of severe myoclonic epilepsy in infancy (SMEI).


Main article: Barbiturates

Barbiturates are drugs that act as central nervous system (CNS) depressants, and by virtue of this they produce a wide spectrum of effects, from mild sedation to anesthesia. The following are classified as anticonvulsants:

  • Phenobarbital (1912). See also the related drug primidone.
  • Methylphenobarbital (1935). Known as mephobarbital in the US. No longer marketed in the UK
  • Metharbital (1952). No longer marketed in the UK or US.
  • Barbexaclone (1982). Only available in some European countries.

Phenobarbital was the main anticonvulsant from 1912 till the development of phenytoin in 1938. Today, phenobarbital is rarely used to treat epilepsy in new patients since there are other effective drugs that are less sedating. Phenobarbital sodium injection can be used to stop acute convulsions or status epilepticus, but a benzodiazepine such as lorazepam, diazepam or midazolam is usually tried first. Other barbiturates only have an anticonvulsant effect at anaesthetic doses.


Main article: Benzodiazepines

The benzodiazepines are a class of drugs with hypnotic, anxiolytic, anticonvulsive, amnestic and muscle relaxant properties. Benzodiazepines act as a central nervous system depressant. The relative strength of each of these properties in any given benzodiazepine varies greatly and influences the indications for which it is prescribed. Long-term use can be problematic due to the development of tolerance and dependency. Of the many drugs in this class, only a few are used to treat epilepsy:

  • Clobazam (1979). Notably used on a short-term basis around menstruation in women with catamenial epilepsy.
  • Clonazepam (1974).
  • Clorazepate (1972).

The following benzodiazepines are used to treat status epilepticus:

  • Diazepam (1963). Can be given rectally by trained care-givers.
  • Midazolam (N/A). Increasingly being used as an alternative to diazepam. This water-soluble drug is squirted into the side of the mouth but not swallowed. It is rapidly absorbed by the buccal mucosa.
  • Lorazepam (1972). Given by injection in hospital.

Nitrazepam, temazepam, and especially nimetazepam are powerful anticonvulsant agents, however their use is rare due to an increased incidence of side effects and strong sedative and motor-impairing properties.


Main article: Bromides

  • Potassium bromide (1857). The earliest effective treatment for epilepsy. There would not be a better drug for epilepsy until phenobarbital in 1912. It is still used as an anticonvulsant for dogs and cats.


Main article: Carbamates

  • Felbamate (1993). This effective anticonvulsant has had its usage severely restricted due to rare but life-threatening side effects.


Main article: Carboxamides

The following are carboxamides:

  • Carbamazepine (1963). A popular anticonvulsant that is available in generic formulations.
  • Oxcarbazepine (1990). A derivative of carbamazepine that has similar efficacy but is better tolerated.

Fatty acids

Main article: Fatty acids

The following are fatty-acids:

Vigabatrin and progabide are also analogs of GABA.

Fructose derivatives

Main article: Fructose

Gaba analogs


Main article: Hydantoins

The following are hydantoins:

  • Ethotoin (1957).
  • Phenytoin (1938).
  • Mephenytoin
  • Fosphenytoin (1996).


Main article: Oxazolidinediones

The following are oxazolidinediones:

  • Paramethadione
  • Trimethadione (1946).
  • Ethadione


Main article: Propionates

  • Beclamide


Main article: Pyrimidinediones


Main article: Pyrrolidines

  • Brivaracetam
  • Levetiracetam (1999).
  • Seletracetam


Main article: Succinimides

The following are succinimides:


Main article: Sulfonamides


Main article: Triazines


Main article: Ureas

  • Pheneturide
  • Phenacemide

Valproylamides (amide derivatives of valproate)

Main article: Amides

  • Valpromide
  • Valnoctamide


The ketogenic diet is a strict medically supervised diet that has an anticonvulsant effect. It is typically used in children with refractory epilepsy.


The vagus nerve stimulator (VNS) is a device that sends electric impulses to the left vagus nerve in the neck via a lead implanted under the skin. It was FDA approved in 1997 as an adjunctive therapy for partial-onset epilepsy.

Marketing approval history

The following table lists anticonvulsant drugs together with the date their marketing was approved in the US, UK and France. Data for the UK and France is incomplete. In recent years, the European Medicines Agency has approved drugs throughout the European Union. Some of the drugs are no longer marketed.

Drug Brand US UK France
acetazolamide Diamox 1953-07-271953-07-27[4] 1988[5]
carbamazepine Tegretol 1974-07-151974-07-15[6][7] 1965[5] 1963[8]
clobazam Frisium 1979[5]
clonazepam Klonopin/Rivotril 1975-06-041975-06-04[9] 1974[5]
diazepam Valium 1963-11-151963-11-15[10]
divalproex sodium Depakote 1983-03-101983-03-10[11]
ethosuximide Zarontin 1960-11-021960-11-02[12] 1955[5] 1962[8]
ethotoin Peganone 1957-04-221957-04-22[13]
felbamate Felbatol 1993-07-291993-07-29[14]
fosphenytoin Cerebyx 1996-08-051996-08-05[15]
gabapentin Neurontin 1993-12-301993-12-30[16] 1993-05May 1993[5][8] 1994-10October 1994[8]
lamotrigine Lamictal 1994-12-271994-12-27[17] 1991-10October 1991[5][8] 1995-05May 1995[8]
levetiracetam Keppra 1999-11-301999-11-30[18] 2000-09-292000-09-29[5][19] 2000-09-292000-09-29[19]
mephenytoin Mesantoin 1946-10-231946-10-23[20]
metharbital Gemonil 1952[21]Cite error: Invalid <ref> tag;

name cannot be a simple integer. Use a descriptive title

methsuximide Celontin 1957-02-081957-02-08[22]
methazolamide Neptazane 1959-01-261959-01-26[23]
oxcarbazepine Trileptal 2000-01-142000-01-14[24] 2000[5]
phenobarbital 1912[5] 1920[8]
phenytoin Dilantin/Epanutin 1938[25][8] 1938[5] 1941[8]
phensuximide Milontin 1953[26][27]
pregabalin Lyrica 2004-12-302004-12-30[28] 2004-07-062004-07-06[5][29] 2004-07-062004-07-06[29]
primidone Mysoline 1954-03-081954-03-08[30] 1952[5] 1953[8]
sodium valproate Epilim 1977-12December 1977[8] 1967-06June 1967[8]
stiripentol Diacomit 2001-12-052001-12-05[31] 2001-12-052001-12-05[31]
tiagabine Gabitril 1997-09-301997-09-30[32] 1998[5] 1997-11November 1997[8]
topiramate Topamax 1996-12-241996-12-24[33] 1995[5]
trimethadione Tridione 1946-01-251946-01-25[34]
valproic acid Depakene/Convulex 1978-02-281978-02-28[35] 1993[5]
vigabatrin Sabril 1989[5]
zonisamide Zonegran 2000-03-272000-03-27[36] 2005-03-102005-03-10[5][37] 2005-03-102005-03-10[37]

See also


  1. Loring, David W ([2005-09-01]]). Cognitive Side Effects of Antiepileptic Drugs in Children. Psychiatric Times XXII (10).
  2. Bittigau P, Sifringer M, Genz K, et al (2002-11-12). Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. PNAS 99 (23): 15089-15094.
  3. 3.0 3.1 3.2 Abou-Khalil BW (2007). Comparative monotherapy trials and the clinical treatment of epilepsy. Epilepsy currents / American Epilepsy Society 7 (5): 127–9.
  4. NDA 008943
  5. 5.00 5.01 5.02 5.03 5.04 5.05 5.06 5.07 5.08 5.09 5.10 5.11 5.12 5.13 5.14 5.15 5.16 5.17 Epilepsy Action: Druglist. Retrieved on 2007-11-01.
  6. NDA 016608 (Initial approval on 1968-03-11 was for trigeminal neuralgia.)
  7. Schain, Richard J. (March 1978). Pediatrics—Epitomes of Progress: Carbamazepine (Tegretol®) in the Treatment of Epilepsy. Western Journal of Medicine 128 (3): 231–232. PMID [1].
  8. 8.00 8.01 8.02 8.03 8.04 8.05 8.06 8.07 8.08 8.09 8.10 8.11 8.12 Loiseau, Pierre Jean-Marie (June 1999). Clinical Experience with New Antiepileptic Drugs: Antiepileptic Drugs in Europe. Epilepsia 40 (Suppl 6): S3–8. PMID 10530675.
  9. NDA 017533
  10. NDA 013263
  11. NDA 018723
  12. NDA 012380
  13. NDA 010841
  14. NDA 020189
  15. NDA 020450
  16. NDA 020235
  17. NDA 020241
  18. NDA 021035
  19. 19.0 19.1 EPAR: Keppra. Retrieved on 2007-11-01.
  20. NDA 006008
  21. NDA 008322
  22. NDA 010596
  23. NDA 011721
  24. NDA 021014
  25. NDA 008762 (Marketed in 1938, approved 1953)
  26. NDA 008855
  27. Kutt, Henn; Resor, Stanley R. (1992). The Medical treatment of epilepsy, 385, New York: Dekker. (first usage)
  28. NDA 021446
  29. 29.0 29.1 EPAR: Lyrica Retrieved on 2007-11-01.
  30. NDA 009170
  31. 31.0 31.1 EPAR: Diacomit.] Orphan designation: 2001-12-05, full authorisation: 2007-01-04 Retrieved on 2007-11-01.
  32. NDA 020646
  33. NDA 020505
  34. NDA 005856
  35. NDA 018081
  36. NDA 020789
  37. 37.0 37.1 EPAR: Zonegran. Retrieved on 2007-11-01

External links

Anticonvulsants edit


Template:Aromatic allylic alcohol anticonvulsants Template:Carboxamides |-


|- Template:Carbamates


Barbiturates edit

{Phenobarbital} {Methylphenobarbital} {Metharbital} {Barbexaclone}

|- |}

This page uses Creative Commons Licensed content from Wikipedia (view authors).